Creagene Inc.
Records under this name other than patents Creagene Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Creagene Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,513,028 | Use of MLN51 gene and protein Lapsed on the fee record Ended Aug 20, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 20, 2025 | From the USPTO record |
| US 7,138,274 | Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP) Term ended Term ended Aug 31, 2024 · From the USPTO record | Term ended | Term ended Aug 31, 2024 | From the USPTO record |
| US 7,101,844 | Cytoplasmic transduction peptides and uses thereof Term ended Term ended Mar 28, 2023 · From the USPTO record | Term ended | Term ended Mar 28, 2023 | From the USPTO record |
| US 6,780,618 | Method for improving genetic stability of foreign insert nucleotide sequence in recombinant poliovirus Lapsed on the fee record Ended Aug 24, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 24, 2016 | From the USPTO record |
| US 6,696,289 | Replication-competent recombinant Sabin type 1 strain of poliovirus Lapsed on the fee record Ended Feb 24, 2016 · From the USPTO record | Lapsed on the fee record | Ended Feb 24, 2016 | From the USPTO record |